ACRF Department of Cancer Biology and Therapeutics
Research institute
John Curtin School of Medical Research, Australian National University, ACT
Amount Granted
$2 million
Year Granted
2015
Cancer Targeted
Breast Cancer
Research Area
The grant has been used to establish the ACRF Department of Cancer Biology and Therapeutics at the ANU John Curtin School of Medical Research (JCSMR).
The ACRF funding will dramatically transform the capabilities available to Professor Ross Hannan’s research and will enable discovery-based research and development of new compounds, drugs and diagnostic approaches for cancer treatment.
New high-technology equipment will allow screening of Australian natural product collections to rapidly identify bioactive components that may be helpful in developing new cancer treatments.
The Centre will utilise Australia’s Chemome (whole sets of small molecule natural products) and explore the existing collections for novel lead compounds that can be developed in to drugs for cancer therapy.
In contrast to the limited chemical diversity of synthetically developed drugs, the structural diversity available within the Australian Chemome is unparalleled.
The Facility was officially opened in February 2017.
